Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by buygold69on Nov 30, 2007 3:25pm
239 Views
Post# 13897530

RE: News

RE: NewsCinemage to dabble with bioenergy (CIG.v Last .025cts) Number of shares outstanding 37,746,486 2007-11-15 10:26 ET - News Release Mr. Edgar Froese reports CINEMAGE SUB AND AFFILIATE SIGN BIOENERGY JOINT VENTURE PROPOSAL Cinemage Corp.'s subsidiary Advanced Cultural Technologies Inc. has signed an agreement (subject to regulatory and shareholder approvals) with its affiliate Cinemage Systems LP to form a joint venture to investigate business expansion opportunities in the development and commercialization of bioenergy technologies. "The joint venture will allow us to continue to evolve our current technology while diversifying the corporation's interests into the alternative energy sector," said Edgar Froese, chief executive officer of Cinemage. Under the terms of the joint venture proposal, the partnership will market up to $1-million in limited partner units carrying a full year-end tax write-off, and will use a substantial portion of proceeds to repay previous marketing advances from ACT, and will thereby finance its joint participation in the new joint venture. Cinemage has, through its wholly owned subsidiary ACT, developed a proprietary market-ready software engine that functions as a platform for securely hosting, distributing and processing financial transactions for the sale or licensing of digital content across the Internet. The corporation now seeks through the announced joint venture to expand its technology research and development business interests into the bioenergy technology sector. "We are by now experienced in the life cycle of developing and refining new technologies," commented Mr. Froese. "Our primary area of biotechnology interest is in wood gasification used to generate electrical power and heat. It is in fact an old process developed in the forties, which now finds itself strategic to environmental protection as a technology that can produce clean sustainable energy from biomass without adding greenhouse gas emissions to the environment and thereby contribute to global warming. Utilizing beetle kill as feed stock, there is an opportunity here to provide efficient power to the public while contributing to the resolution of the immense problem created by the Mountain Pine Beetle infestation in central British Columbia." Cinemage holds an option to acquire all partnership units in the future in exchange for common stock of the corporation issued at fair market value. As a related-party transaction, the joint venture agreement is subject to approval by minority shareholders of Cinemage and the TSX Venture Exchange. We seek Safe Harbor.
Bullboard Posts